Login
| TI Ref No : | 524050573 |
|---|---|
| Description : | The Dak-gesundheit Is Entering Into A Non-exclusive Discount Agreement For The Active Ingredient Tocilizumab (only Pre-filled Syringe And Pre-filled Pen) For The Period From December 1, 2025, To November 30, 2027. This Procedure Is Expected To Fall Outsid |
| Date : | 2025-10-18 |
| Deadline : | 2026-04-16 |
| Document Type : | Tenders |
